A.V. Romanenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
A.V. Romanenko has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ekaterina G. Seliverstova
Sklifosovsky Research Institute for Emergency Care
1 shared publication - Ksenia Popovskaya
Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication - N. A. Gorbachev
I.M. Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication - O. E. Turgunkhujaev
State Scientific Centre of the Russian Federation – Federal Medical Biophysical Centre n. a. A. I. Burnazyan
1 shared publication - V. V. Murzo
Sechenov First Moscow State Medical University (Sechenov University)
1 shared publication
Latest Publications
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 22 (2)
Calcitonin gene-related peptide in pathophysiology of migraine
Migraine is one of the most common neurological diseases manifested by headache attacks. Calcitonin-gene related peptide (CGRP) plays a key role in the pathophysiology of migraine. The release of CGRP during a migraine attack leads to cranial vasodilation and neurogenic inflammation. As a result, the sensory fibres of the trigeminal nerve become activated and the transmission of pain impulses to the brain is modulated. Due to the wide representation of CGRP receptors in the brain, the calcitonin-gene related peptide is an actively studied target in studies of antimigraine drugs. This review presents the mechanisms of action, a description of the structure, receptors of the calcitonin gene-related peptide in the pathophysiology of migraine and demonstrates new therapeutic options related to CGRP.
- 23 April 2024
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 22 (2)
Calcitonin gene-related peptide in pathophysiology of migraine
Migraine is one of the most common neurological diseases manifested by headache attacks. Calcitonin-gene related peptide (CGRP) plays a key role in the pathophysiology of migraine. The release of CGRP during a migraine attack leads to cranial vasodilation and neurogenic inflammation. As a result, the sensory fibres of the trigeminal nerve become activated and the transmission of pain impulses to the brain is modulated. Due to the wide representation of CGRP receptors in the brain, the calcitonin-gene related peptide is an actively studied target in studies of antimigraine drugs. This review presents the mechanisms of action, a description of the structure, receptors of the calcitonin gene-related peptide in the pathophysiology of migraine and demonstrates new therapeutic options related to CGRP.